LY2584702

LY2584702 Basic information
Product Name:LY2584702
Synonyms:LY2584702;LY-2584702 (free base);LY2584702 TsOH;4-[4-[4-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methyl-imidazol-2-yl]-1-piperidyl]-1H-pyrazolo[3,4-d]pyrimidine LY2584702;4-[4-[4-[4-Fluoro-3-(trifluoromethyl)phenyl]-1-methyl-1H-imidazol-2-yl]-1-piperidinyl]-1H-pyrazolo[3,4-d]pyrimidine;4-[4-[4-[4-Fluoro-3-(trifluoromethyl)phenyl]-1-methylimidazol-2-yl]piperidin-1-yl]-1H-pyrazolo;LY2584702 BASE;LY-2584702 free base (LY2584702)
CAS:1082949-67-4
MF:C21H19F4N7
MW:445.42
EINECS:
Product Categories:Inhibitors
Mol File:1082949-67-4.mol
LY2584702 Structure
LY2584702 Chemical Properties
storage temp. RT (des.)
solubility Soluble in DMSO (up to 1 mg/ml) or in DMF (up to 3 mg/ml).
form solid
color Yellow
Stability:Stable for 2 years from date of purchase as supplied. Solutions in DMSO or DMF may be stored at -20° for up to 3 months.
Safety Information
HS Code 2933998090
MSDS Information
LY2584702 Usage And Synthesis
DescriptionLYS6K2 (1082949-67-4) is a selective inhibitor of the p70 ribosomal S6 kinase (S6K).1 Blocks the phosphorylation of S6 at concentrations as low as 0.1-0.3 μM with no activity at GSK3β and Erk1/2 at 10 μM.2?LYS6K2 is a useful tool to dissect insulin receptor signaling pathways and was employed to show that the action of mTORC1 on SREB P-1c expression is not mediated by S6K.2?Cell permeable.
UsesLY 2584702 is an orally available inhibitor of p70S6K signalling and potential antineoplastic activity. Used in combination with Erlotinib or Everolimus as an anti-tumor treatment.
References1) Fenton et al. (2011), Functions and regulation of the 70kDa ribosomal S6 kinases; Int. J. Biochem. Cell Biol., 43 47 2) Li et al. (2010), Bifurcation of insulin signaling pathway in the rat liver: mTORC1 required for stimulation of lipogenesis, but no inhibition of gluconeogenesis; Proc. Natl. Acad. Sci. USA 107 3441
LY2584702 Preparation Products And Raw materials
AZD-9291 LY 294002 HYDROCHLORIDE Cyclo[Phe-Tyr-Lys(iPr)-D-Arg-2-Nal-Gly-D-Glu]-Lys(iPr)-NH2 (S)-3-fluoro-4-(4-((2-(3-fluorophenyl)pyrrolidin-1-yl)methyl)phenoxy)benzamide LY 88074 LY-364947 LY2409881 trihydrochloride ABT 737 LY 2784544 LY3214996 2-(4-((4-((1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl)oxy)pyridin-2-yl)amino)pyridin-2-yl)propan-2-ol SB 431542 Etalocib Verteporfin LY2228820 Y27632 (hydrochloride) LY-2562175 Everolimus

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.